122 related articles for article (PubMed ID: 38219464)
21. DNA walker-powered ratiometric SERS cytosensor of circulating tumor cells with single-cell sensitivity.
Xiong J; Dong C; Zhang J; Fang X; Ni J; Gan H; Li J; Song C
Biosens Bioelectron; 2022 Oct; 213():114442. PubMed ID: 35679649
[TBL] [Abstract][Full Text] [Related]
22. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma.
Aktar S; Hamid FB; Gamage SMK; Cheng T; Parkneshan N; Lu CT; Islam F; Gopalan V; Lam AK
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902476
[TBL] [Abstract][Full Text] [Related]
23. Imaging immune checkpoint networks in cancer tissues with supermultiplexed SERS nanoprobes.
Li J; Liu F; Bi X; Ye J
Biomaterials; 2023 Nov; 302():122327. PubMed ID: 37716283
[TBL] [Abstract][Full Text] [Related]
24. SERS and fluorescence detection of circulating tumor cells (CTCs) with specific capture-release mode based on multifunctional gold nanomaterials and dual-selective recognition.
Wang J; Zhang R; Ji X; Wang P; Ding C
Anal Chim Acta; 2021 Jan; 1141():206-213. PubMed ID: 33248653
[TBL] [Abstract][Full Text] [Related]
25. Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy.
Zhou Y; Zhou J; Hao X; Shi H; Li X; Wang A; Hu Z; Yang Y; Jiang Z; Wang T
Breast Cancer Res Treat; 2023 Jul; 200(2):281-291. PubMed ID: 37227611
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer.
Kulasinghe A; Kapeleris J; Kimberley R; Mattarollo SR; Thompson EW; Thiery JP; Kenny L; O'Byrne K; Punyadeera C
Cancer Med; 2018 Dec; 7(12):5910-5919. PubMed ID: 30565869
[TBL] [Abstract][Full Text] [Related]
27. Dynamic monitoring of PD-L1 and Ki67 in circulating tumor cells of metastatic non-small cell lung cancer patients treated with pembrolizumab.
Spiliotaki M; Neophytou CM; Vogazianos P; Stylianou I; Gregoriou G; Constantinou AI; Deltas C; Charalambous H
Mol Oncol; 2023 May; 17(5):792-809. PubMed ID: 36177552
[TBL] [Abstract][Full Text] [Related]
28. Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells.
Brechbuhl HM; Vinod-Paul K; Gillen AE; Kopin EG; Gibney K; Elias AD; Hayashi M; Sartorius CA; Kabos P
Mol Carcinog; 2020 Oct; 59(10):1129-1139. PubMed ID: 32822091
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Circulating Tumor and Cancer Stem Cells Provides New Opportunities in Diagnosis and Treatment of Small Cell Lung Cancer.
Skurikhin EG; Ermakova N; Zhukova M; Pershina O; Pan E; Pakhomova A; Kogai L; Goldberg V; Simolina E; Skurikhina V; Widera D; Kubatiev A; Morozov SG; Kushlinskii N; Dygai A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142766
[TBL] [Abstract][Full Text] [Related]
30. Novel nitrocellulose membrane substrate for efficient analysis of circulating tumor cells coupled with surface-enhanced Raman scattering imaging.
Zhang P; Zhang R; Gao M; Zhang X
ACS Appl Mater Interfaces; 2014 Jan; 6(1):370-6. PubMed ID: 24325273
[TBL] [Abstract][Full Text] [Related]
31. Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS-Titanium-Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release.
Kwizera EA; Ou W; Lee S; Stewart S; Shamul JG; Xu J; Tait N; Tkaczuk KHR; He X
ACS Nano; 2022 Jul; 16(7):11374-11391. PubMed ID: 35797466
[TBL] [Abstract][Full Text] [Related]
32. Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.
Sinoquet L; Jacot W; Gauthier L; Pouderoux S; Viala M; Cayrefourcq L; Quantin X; Alix-Panabières C
Clin Chem; 2021 Nov; 67(11):1503-1512. PubMed ID: 34355741
[TBL] [Abstract][Full Text] [Related]
33. Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer.
Chen YL; Huang WC; Lin FM; Hsieh HB; Hsieh CH; Hsieh RK; Chen KW; Yen MH; Lee J; Su S; Marfatia T; Chang SE; Sundar P; Patterson B; Watson D; Mei R; Javey M
Cancer Immunol Immunother; 2019 Jul; 68(7):1087-1094. PubMed ID: 31089757
[TBL] [Abstract][Full Text] [Related]
34. SERS Multiplex Profiling of Melanoma Circulating Tumor Cells for Predicting the Response to Immune Checkpoint Blockade Therapy.
Li J; Wuethrich A; Zhang Z; Wang J; Lin LL; Behren A; Wang Y; Trau M
Anal Chem; 2022 Oct; 94(42):14573-14582. PubMed ID: 36222247
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
[TBL] [Abstract][Full Text] [Related]
36. PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Dall'Olio FG; Gelsomino F; Conci N; Marcolin L; De Giglio A; Grilli G; Sperandi F; Fontana F; Terracciano M; Fragomeno B; Tober N; Manferrari G; Brocchi S; Golfieri R; Fiorentino M; Ardizzoni A
Clin Lung Cancer; 2021 Sep; 22(5):423-431. PubMed ID: 33849808
[TBL] [Abstract][Full Text] [Related]
37. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
Messaritakis I; Politaki E; Kotsakis A; Dermitzaki EK; Koinis F; Lagoudaki E; Koutsopoulos A; Kallergi G; Souglakos J; Georgoulias V
PLoS One; 2017; 12(7):e0181211. PubMed ID: 28719656
[TBL] [Abstract][Full Text] [Related]
39. Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer.
Acheampong E; Allsopp RC; Page K; Wadsley MK; Beasley AB; Coombes RC; Shaw JA; Gray ES
Clin Chem; 2024 Jan; 70(1):234-249. PubMed ID: 38175603
[TBL] [Abstract][Full Text] [Related]
40. Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.
Adams DL; Adams DK; He J; Kalhor N; Zhang M; Xu T; Gao H; Reuben JM; Qiao Y; Komaki R; Liao Z; Edelman MJ; Tang CM; Lin SH
Clin Cancer Res; 2017 Oct; 23(19):5948-5958. PubMed ID: 28679765
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
